DIVENCE Range

DIVENCE® is 'That EXTRA to transform the ordinary into EXTRA-ORDINARY’

DIVENCE® is not only a combinable range of vaccines, but a tool to enhance the performance and health control on farm, helping vets and farmers anticipate and work in a more organized way.

DIVENCE PENTA

Composition

  • Live attenuated BRSV, strain Lym-56
  • Live gE- tk- double-gene deleted BoHV type 1, strain CEDDEL
  • Inactivated PI-3 virus, strain SF4
  • E2 recombinant protein from BVDV-1
  • E2 recombinant protein from BVDV-2

Characteristics

  • IBR Marker
  • Double BVD marker
  • BVD Foetal Protection
  • Stimulates active immunity against viral BRD
DIVENCE PENTA

Presentations

  • 5 doses (10 ml vial)
  • 10 doses (20 ml vial)
  • 20 doses (40 ml vial)

* Not all pack sizes may be marketed.

Vaccination protocol

  • Intramuscular use. 2 ml
  • From 10 weeks of age
DIVENCE TETRA

Composition

  • Live attenuated BRSV, strain Lym-56
  • Inactivated PI-3 virus, strain SF4
  • E2 recombinant protein from BVDV-1
  • E2 recombinant protein from BVDV-2

Characteristics

  • Double BVD marker
  • BVD Foetal Protection
  • Stimulates active immunity against viral BRD
DIVENCE TETRA

Presentations

  • 5 doses (10 ml vial)
  • 10 doses (20 ml vial)
  • 20 doses (40 ml vial)

* Not all pack sizes may be marketed.

Vaccination protocol

  • Intramuscular use. 2 ml
  • From 10 weeks of age
DIVENCE IBR

Composition

  • Live gE- tk- double-gene deleted BoHV type 1, strain CEDDEL

Characteristics

  • IBR Marker
DIVENCE IBR

Presentations

  • 5 doses (10 ml vial)
  • 20 doses (40 ml vial)
  • 40 doses (80 ml vial)
  • 50 doses (100 ml vial)

* Not all pack sizes may be marketed.

Vaccination protocol

  • Intramuscular use. 2 ml
  • From 10 weeks of age
DIVENCE TRI

Composition

  • Live gE- tk- double-gene deleted BoHV type 1, strain CEDDEL

Characteristics

  • IBR Marker
DIVENCE TRI

Presentations

  • 5 doses (10 ml vial)
  • 20 doses (40 ml vial)
  • 40 doses (80 ml vial)
  • 50 doses (100 ml vial)

* Not all pack sizes may be marketed.

Vaccination protocol

  • Intramuscular use. 2 ml
  • From 10 weeks of age

Consult product availability in your own country* or contact your representative for further information